Tom Castaneda from South Texas Health Systems discusses Sleep apnea on the upcoming episode of STHS TV on NBC 23. This ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Many major maladies have been linked to disturbed slumber caused by sleep apnea, high blood pressure, heart problems a ...

Medical conditions that deprive the testes of oxygen, such as sleep apnea, may be contributing to the decline in male fertility observed over the past 50 years, a new study suggests.

The pathophysiology of residual sleepiness in treated obstructive sleep apnoea (OSA) remains poorly understood. Animal models ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

Recent research found that eating cheese can lower the risk of developing sleep apnea. Experts explain the link but warn ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

An update from Mineralys Therapeutics, Inc. ( (MLYS) ) is now available. Mineralys Therapeutics announced that the U.S. FDA ...